文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

严重创伤患者急性ICU复苏:我们需要新策略吗?

Acute intensive care unit resuscitation of severely injured trauma patients: Do we need a new strategy?
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论严重创伤出血性休克患者入ICU后至乳酸正常化期间,较大静脉晶体液量与更差结局相关,提示该阶段液体管理有待标准化。

该回顾性队列研究链接创伤登记与电子病历(2012-2015),纳入初始乳酸≥4 mmol/L且后续乳酸正常化(≤2 mmol/L)的成人,排除孤立性头部AIS≥3者,共337例。重点分析ICU入住至乳酸正常化期间的静脉晶体液 duration、总量及1-L bolus比例。中位乳酸正常化时间15小时,中位晶体液量3.7 L。调整协变量后,较大晶体液量与更长的ICU停留、机械通气时间及急性肾损伤相关。结论提示急性ICU复苏阶段液体管理变异大,较大液量与更差结局相关,需进一步研究并标准化。

要点

  • 研究纳入初始乳酸≥4 mmol/L且乳酸正常化(≤2 mmol/L)的成人创伤患者,排除孤立性头部AIS≥3者,共337例。
  • ICU入住至乳酸正常化中位时间15小时(IQR 7-25),中位静脉晶体液量3.7 L(IQR 1.5-6.4 L)。
  • 按损伤严重度分层后,液体时长与总量的上下四分位间仍存在四倍差异。
  • 较大晶体液量与更长ICU停留、更长机械通气时间及急性肾损伤相关。
  • 167例在入ICU后6小时内至少接受一次0.5-L bolus,提示该阶段液体管理变异大。

适用人群与场景

  • 成人创伤患者,初始乳酸≥4 mmol/L且记录到乳酸正常化(≤2 mmol/L)。
  • 排除孤立性头部简明损伤定级(AIS)评分≥3的患者。
  • 研究场景为ICU入住至乳酸正常化期间的急性复苏阶段。

诊断标准与关键阈值

  • 初始乳酸水平≥4 mmol/L。
  • 乳酸正常化定义为≤2 mmol/L。
  • 排除标准:孤立性头部AIS评分≥3。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:回顾性队列研究,链接创伤登记与电子病历数据(2012-2015),单中心数据来源未明确。
  • 样本量:337例成人创伤患者。
  • 主要暴露:ICU入住至乳酸正常化期间的静脉晶体液总量、持续时间及1-L bolus比例。
  • 主要结局:较大晶体液量与更长ICU停留、更长机械通气时间及急性肾损伤相关(调整协变量后)。
  • 其他结果:中位乳酸正常化时间15小时(IQR 7-25),中位晶体液量3.7 L(IQR 1.5-6.4 L),167例接受至少一次0.5-L bolus。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(治疗/临床管理),证据等级Level IV。
  • 局限:观察性设计不能证明因果;单中心数据来源(原文未明确多中心);排除孤立性头部AIS≥3者,外推受限。

对床旁实践的改变

  • 提示ICU急性复苏阶段静脉晶体液量存在显著变异,较大液量与更差结局相关,应关注该阶段液体管理。
  • 适用人群为初始乳酸≥4 mmol/L且乳酸正常化的成人创伤患者,不适用于孤立性头部AIS≥3者。
  • 原文未提出具体液体剂量或标准化方案,不能据此设定决策阈值。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Unlike recent advances in blood product resuscitation, intravenous crystalloid (IVF) use after intensive care unit (ICU) admission in hemorrhagic shock has received less attention and current recommendations are based on limited evidence. To address this knowledge gap, we aimed to determine associations between IVF administration during acute ICU resuscitation and outcomes. We hypothesized that larger IVF volumes are associated with worse outcomes.

METHODS: We linked our trauma registry with electronic health record data (2012-2015) to identify adults with an initial lactate level of ≥4 mmol/L and documented lactate normalization (≤2 mmol/L), excluding those with isolated head Abbreviated Injury Scale score ≥3. We focused on the period from ICU admission to lactate normalization, analyzing duration, volume of IVF, and proportion of volume as 1-L boluses. We used linear regression to determine associations with ICU length of stay and duration of mechanical ventilation in survivors, and logistic regression to identify associations with acute kidney injury and home discharge while adjusting for important covariates.

RESULTS: We included 337 subjects. Median time to lactate normalization was 15 hours (interquartile range, 7-25 hours), and median IVF volume was 3.7 L (interquartile range, 1.5-6.4 L). The fourfold difference between the upper and lower quartiles of both duration and volume remained after stratifying by injury severity. Hourly volumes tapered over time but persistently aggregated at 0.5 and 1 L, with 167 subjects receiving at least one 0.5-L bolus for 6 hours after ICU admission. Administration of larger volumes was associated with longer ICU length of stay and duration of mechanical ventilation, as well as acute kidney injury.

CONCLUSION: There is substantial variation in volume administered during acute ICU resuscitation, both absolutely and temporally, despite accounting for injury severity. Administration of larger volumes during acute ICU resuscitation is associated with worse outcomes. There is an opportunity to improve outcomes by further investigating and standardizing this important phase of care.

LEVEL OF EVIDENCE: Therapeutic/care management, level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Beni CE, Arbabi S, Robinson BRH, et al. Acute intensive care unit resuscitation of severely injured trauma patients: Do we need a new strategy? J Trauma Acute Care Surg. 2021. PMID: 34347741. doi:10.1097/TA.0000000000003373

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。